L, P., ML, J., C, R., F, L., J, C., Y, I., . . . F, M. (2026). Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression. Proceedings of the National Academy of Sciences of the United States of America, 123(24), e2526271123. https://doi.org/10.1073/pnas.2526271123
Chicago Style (17th ed.) CitationL, Pechtimaldjian, et al. "Telocyte-derived Pentraxin 3 Enables Vascular Pruning as a Key Driver in Infantile Hemangioma Regression." Proceedings of the National Academy of Sciences of the United States of America 123, no. 24 (2026): e2526271123. https://doi.org/10.1073/pnas.2526271123.
MLA (9th ed.) CitationL, Pechtimaldjian, et al. "Telocyte-derived Pentraxin 3 Enables Vascular Pruning as a Key Driver in Infantile Hemangioma Regression." Proceedings of the National Academy of Sciences of the United States of America, vol. 123, no. 24, 2026, p. e2526271123, https://doi.org/10.1073/pnas.2526271123.